Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Phyo Than Htoo, Ph.D.

Concepts (79)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Benzhydryl Compounds420249412.280 Why?
Glucosides420245332.160 Why?
Dipeptidyl-Peptidase IV Inhibitors420243341.640 Why?
Diabetes Mellitus, Type 2102024122891.230 Why?
Hypoglycemic Agents10202431490.890 Why?
Atherosclerosis3202435180.820 Why?
Cardiovascular Diseases82024157600.710 Why?
Renal Insufficiency, Chronic2202322900.640 Why?
Hypoglycemia120238880.540 Why?
Heart Failure62024118480.520 Why?
Angiotensin Receptor Antagonists1201910310.430 Why?
Angiotensin-Converting Enzyme Inhibitors1201915230.420 Why?
Medicare7202467850.370 Why?
Influenza, Human1202215280.360 Why?
Patient Acceptance of Health Care1202431640.360 Why?
Pneumonia1202221310.350 Why?
Sulfonylurea Compounds220232210.320 Why?
Glucose5202343500.320 Why?
Colorectal Neoplasms2201968530.300 Why?
Myocardial Infarction32024118900.250 Why?
United States102024724480.200 Why?
Sodium3202215940.200 Why?
Stroke2202499520.200 Why?
Oseltamivir12022760.200 Why?
Electronics120223150.180 Why?
Aged1120241691430.180 Why?
Sodium Chloride Symporter Inhibitors12019780.170 Why?
Hypertension1201985950.170 Why?
Cohort Studies72024413370.160 Why?
Diabetes Mellitus1201658900.150 Why?
Calcium Channel Blockers120196940.130 Why?
Hospitalization32024107890.120 Why?
Adrenergic beta-Antagonists1201912590.110 Why?
Humans1720247606130.110 Why?
Thiazolidinediones120164650.110 Why?
Aged, 80 and over52024589800.100 Why?
Vulnerable Populations120176960.100 Why?
Health Care Costs1202432580.090 Why?
Analgesia, Epidural120143300.090 Why?
Antihypertensive Agents1201920610.080 Why?
Proportional Hazards Models32019125310.080 Why?
Incidence22019213910.080 Why?
Antiviral Agents1202230610.080 Why?
Insulin1202365960.080 Why?
Chemotherapy, Adjuvant1201735300.080 Why?
Female920243912460.070 Why?
Male720243597180.070 Why?
Randomized Controlled Trials as Topic12023103430.070 Why?
Adolescent22024878090.060 Why?
Retrospective Studies32022803450.060 Why?
Stomach Neoplasms1201414240.060 Why?
Pain, Postoperative1201417200.060 Why?
Medicaid1201728150.060 Why?
Algorithms12024139820.060 Why?
Anti-Bacterial Agents1202274080.050 Why?
Early Detection of Cancer1201732020.050 Why?
Decision Trees120245060.050 Why?
Matched-Pair Analysis120212840.050 Why?
SEER Program2201715300.040 Why?
Breast Neoplasms22017210290.040 Why?
Adult320242200070.040 Why?
Treatment Outcome22024649810.040 Why?
Ohio120173330.030 Why?
Epidemiologic Studies120196700.030 Why?
Antineoplastic Agents12017136270.030 Why?
Middle Aged320242203590.030 Why?
Neoplasm Staging22017111520.030 Why?
Information Storage and Retrieval120178220.020 Why?
Age of Onset1201733020.020 Why?
Population Surveillance1201726080.020 Why?
Poverty1201726950.020 Why?
Odds Ratio1201797160.020 Why?
Comorbidity12017105530.010 Why?
Databases, Factual1201780220.010 Why?
Case-Control Studies12017220520.010 Why?
Logistic Models12014133120.010 Why?
Time Factors12019401390.010 Why?
Neoplasm Recurrence, Local1201492780.010 Why?
Risk Factors12017743330.010 Why?
Htoo's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (79)
Explore
_
Co-Authors (9)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.